SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is currently trending due to its exceptionally low public float and high insider ownership, drawing intense comparisons to recent high-flying SPACs like AFJK. The community is highly bullish, anticipating significant price appreciation as a potential business combination announcement approaches for this US-based SPAC. Traders are actively discussing its potential for explosive moves driven by supply scarcity, aligning with patterns observed in other low-float market plays.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending due to widespread discussion around year-end tax loss selling and persistent selling from early investors, which is currently driving significant downward pressure. Community sentiment remains sharply divided, with some seeing current levels as a compelling buying opportunity given the company's profitability and growth, while others emphasize ongoing dilution concerns and a challenging market backdrop.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending due to the recent FDA approval of NEREUS (tradipitant), marking the first new motion sickness drug in over four decades. The community is actively discussing its potential to alleviate GLP-1 induced nausea, viewing this as a significant market opportunity and a catalyst for potential buyouts. While some initially expressed mixed reactions to price action, many believe the stock's long-term value and additional pipeline catalysts are not yet fully reflected.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending amid a contentious and repeatedly postponed shareholder vote on increasing authorized shares, sparking intense debate over its future funding and growth strategy. Bulls anticipate significant, often classified, government contracts and strategic benefits from the Ask Sage acquisition, viewing current price movements as short-term manipulation. Conversely, skeptics express frustration with management, citing a lack of tangible contract announcements and fearing potential dilution, leading to a polarized community discussion.

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

Aimei Health Technology Co Ltd (AFJK) is trending as traders speculate on a classic "China IPO squeeze" due to its notably low float and thin share structure. The community is actively discussing its highly volatile, casino-like movements, frequent trading halts, and comparing its potential for rapid price swings to similar recent Chinese tickers.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending amidst intense speculation regarding an unconfirmed FDA decision on its relacorilant drug for Cushing's Syndrome, with community chatter divided between rumored rejection causing panic selling and calls to buy the dip. The immediate uncertainty around this key pipeline asset, alongside its existing revenue-generating drug Korlym and other promising indications like ovarian cancer, fuels a volatile debate among investors.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending amidst mixed analyst sentiment driven by concerns over crypto trading volumes, despite a strong 2025 performance. The community is buzzing with frustration over app glitches and modest rewards from recent holiday giveaways, fueling discussions about the platform's reliability and marketing approach. Investors are keenly watching how its crypto correlation and new ventures like prediction markets will shape its near-term outlook.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is experiencing heightened volatility as the CME implements multiple margin requirement hikes, fueling intense community debate over market manipulation. Many perceive these actions as a concerted effort to suppress prices and liquidate leveraged positions, especially with reported disparities between paper and physical silver values globally. Despite calls of a "rigged game" and comparisons to past crashes, a strong bullish contingent anticipates a significant long-term rally driven by robust industrial demand and ongoing concerns about supply.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is currently experiencing a surge in attention fueled by high expectations for its upcoming earnings report, with the community anticipating strong revenue growth driven by its high-margin drug Recorlev. Investors are also keenly focused on the company's pathway to sustained profitability and the long-term potential of its pipeline, particularly the promising XP-8121, which analysts believe could achieve blockbuster status. This positive outlook is supported by recent analyst target upgrades and a perceived de-risked profile, positioning Xeris for significant growth within the biopharma sector.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending due to high anticipation for upcoming FDA decisions regarding AXS-05 for Alzheimer's agitation and AXS-12 for narcolepsy, with the community optimistic about potential approvals. This regulatory excitement is complemented by strong, consistent prescription growth and expanding market access for its major depressive disorder treatment, Auvelity. Investors are keenly focused on these catalysts and the company's broader CNS pipeline, despite some impatience with communication around timelines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NextPlat's Global Telesat Expands 5G and Artificial Intelligence-Powered Internet of Things (IoT) Offerings Through New Distribution Agreement with Telit Cinterion

NextPlat's Global Telesat Expands 5G and Artificial Intelligence-Powered Internet of Things (IoT) Offerings Through New Distribution Agreement with Telit Cinterion NextPlat's Global Telesat Expands...

NextPlat Expects Significant Sequential Quarterly Growth in 340B Revenue in the Fourth Quarter of 2025 as it Further Expands its Business Development Efforts

NextPlat Expects Significant Sequential Quarterly Growth in 340B Revenue in the Fourth Quarter of 2025 as it Further Expands its Business Development Efforts NextPlat Expects Significant Sequential...

NextPlat Corp Q3 Loss Narrows

(RTTNews) - NextPlat Corp (NXPL) revealed Loss for third quarter of -$2.19 million...

NextPlat Reports Third Quarter 2025 Results

NextPlat Reports Third Quarter 2025 Results NextPlat Reports Third Quarter 2025 Results PR Newswire HALLANDALE BEACH, Fla., Nov. 13, 2025 Company Reports $13.8M in Q3Revenue as Refocusing and Cost...

NextPlat's Healthcare Division Awarded Multi-State Prescription Fulfillment Contract by Virtual Healthcare Provider DevotedDOc

NextPlat's Healthcare Division Awarded Multi-State Prescription Fulfillment Contract by Virtual Healthcare Provider DevotedDOc NextPlat's Healthcare Division Awarded Multi-State Prescription...

NextPlat Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

NextPlat Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement NextPlat Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price...

NextPlat Names Amanda L. Ferrio, Vice President of Accounting & Finance, as its New Chief Financial Officer

NextPlat Names Amanda L. Ferrio, Vice President of Accounting & Finance, as its New Chief Financial Officer NextPlat Names Amanda L. Ferrio, Vice President of Accounting & Finance, as its New Chief...

NextPlat Corp. (NXPL) moved in a $0.53-$0.80 range last week before ending Friday's session down 8.4% at $0.6159.The stock, which has about 5,000 followers on Stocktwits, saw message volume spike by about 3,100 by late Sunday relative to the levels a week ago.&nbsp;Florida-based NextPlat is a healthcare and e-commerce company operating in Europe, North America, South America, Asia and Pacific, and Africa.It also operates an e-commerce communications division that offers voice, data, tracking, and Internet of Things (IoT) products and services worldwide. Additionally, through its over-the-counter traded Progressive Care subsidy, it provides pharmacy and healthcare data management services in the U.S.Late Friday, the company said the U.S.-China tariffs will materially impact anticipated sales of U.S. products into China.The company plans to pause certain initiatives within its e-commerce development program launched in April 2023 to help the U.S.-based businesses reach the vast Chinese consumer market through major online platforms like Alibaba's Tmall.&nbsp;This includes the plan to launch a new line of vitamins and supplements under the "Florida Sunshine" brand name, as these offerings would be subject to the increased tariffs and would face significant import costs, reducing its ability to compete with locally produced products.The company said it is still reviewing opportunities to sell its Florida Sunshine products in other markets.NextPlat also intends to continue selling OPKO Health, Inc. (NASDAQ: OPK) products in China.On Stocktwits, retail sentiment toward the NextPlat stock remained 'extremely high' (93/100).<figure class="image"><img style="aspect-ratio:641/139;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_14_at_5_20_30_AM_png_a38af6efc9.webp" alt="Screenshot 2025-04-14 at 5.20.30 AM.png" width="641" height="139"><figcaption>NXPL sentiment and message volume as of 5:21 a.m. ET, April 14 | source: Stocktwits</figcaption></figure>A bullish user said that once the tariff dust settles, NextPlat will be a winner as U.S. companies look for ways to sell their products abroad.<stembedurl>https://stocktwits.com/Peace_of_God/message/611470210</stembedurl>Short interest in NextPlat stock is a very low 0.30%.NextPlat stock has lost nearly 43% so far this year. In early premarket trading on Monday, the stock fell over 4%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sound-hound-ai-super-micro-c3-ai-among-ai-stocks-with-highest-short-interest/chfzCRqRb9z">SoundHound AI, Super Micro, C3.ai Among AI Stocks With Highest Short Interest: Here's How Retail Is Positioned</a>

This Nano-Cap E-Commerce Play Saw 3,100% Jump In Retail Chatter Last Week: What's Behind The Surge?

Late Friday, the company said the U.S.-China tariffs will have a material impact on anticipated sales of U.S. products into China.

Equity

Late Friday, the company said the U.S.-China tariffs will have a material impact on anticipated sales of U.S. products into China.


NextPlat Corp. engages in the provision of satellite-based services and solutions for commercial, government and individual users. The firm’s services include satellite communication solutions, emergency location systems, high-speed satellite internet and global asset and personnel monitoring, customized ground station systems and custom product design. It operates through the e-Commerce Operations and Healthcare Operations segments. The e-Commerce Operations segment refers to acquiring and leasing, primarily an e-commerce platform to collaborate with businesses to optimize their ability to sell their goods online, domestically, and internationally. The Healthcare Operations segment refers TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, compounded medications, tele pharmacy services, anti-retroviral medications, and medication therapy management. The company was founded in 1997 and is headquartered in Hallandale Beach, FL.

NXPL
NextPlat Corp

Feed

News

Sentiment

Fundamentals

Info

Latest NXPL News

NXPLNextPlat Corp